Format

Send to

Choose Destination
Trends Immunol. 2001 Feb;22(2):92-6.

Structured treatment interruptions to control HIV-1 and limit drug exposure.

Author information

1
The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA. Montaner@wistar.upenn.edu

Abstract

Although therapy-mediated suppression of HIV-1 is effective and results in a degree of immune reconstitution, the complications resulting from life-long treatment emphasize the need for alternatives. This review discusses the use of structured interruptions in antiviral therapy to induce drug-free periods of immune-mediated control of HIV-1. Such an approach has the ultimate objective of harnessing anti-viral immune responses, reducing drug exposure (toxicity and cost) and potentially extending the clinical benefits of a suppressive treatment regimen.

PMID:
11286710
DOI:
10.1016/s1471-4906(00)01809-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center